US Government Concedes Hep B Vaccine Causes Systemic Lupus Erythematosus
Posted on April 25, 2011 by ChildHealthSafety
Here we present the US Federal Court’s decision and order in full below.
The claimant in this case was dead
when the damages were awarded. Tambra Harris died on November 9, 2009.
Tambra’s mother and Administratix of her estate, Louvonia Deniece
Harris, was substituted as petitioner, and an amended petition was filed
on October 15, 2010.
Hepatitis B vaccine is given to US infants at birth for a disease which they are not at risk of.
Why? At risk groups are intravenous
“recreational” drug abusers and those who practice unsafe sex – which
rules out new born babies.
Whilst the risk factors for babies have changed little, there is now impressive evidence that for a preventive measure, hepatitis B vaccine is remarkable for the frequency, variety and severity of complications from its use. The toxicity of this vaccine is so unusual that, even if crucial data are regrettably concealed or covered by Court order, scientific evidence is already far higher than normally needed to justify severe restrictive measures.“Quote from French expert Dr. Marc Girard. See CHS article below for full details: UK Government Caught Lying On Baby Hep B Vax Safety. Whilst other evidence is embargoed by the French Courts, Dr Girard has been able to publish a scientific review of the unembargoed evidence from the French Courts of the vaccine’s hazards (Autoimmun Rev 2005; 4: 96-100). Dr Girard shows that French health authorities suppress studies demonstrating serious risks. Hepatitis B vaccine has been shown in many peer reviewed research papers [including from Harvard University - detailed references at end] to be associated with numerous infant deaths in the USA and Europe, multiple sclerosis and numerous chronic auto-immune disorders [see below for more details].
TO BE PUBLISHED - Stipulated Damages; Hepatitis B Vaccine; Alleged Injuries Include Systemic Lupus Erythematosus (SLE)
_______________________________________
LOUONIA DENIECE HARRIS,
Administratrix of the Estate of TAMBRA
HARRIS,
Petitioner,LOUONIA DENIECE HARRIS,
Administratrix of the Estate of TAMBRA
HARRIS,
v.
SECRETARY OF THE DEPARTMENT OF
HEALTH AND HUMAN SERVICES,
Respondent.
______________________________________
STIPULATED DAMAGES DECISION1
On August 29, 2001, Tambra Harris
(“petitioner”), filed a petition for compensation alleging that she
suffered certain injuries as a result of receiving a vaccination. 2
Among the injuries petitioner alleged
that she had suffered as a result of receiving a hepatitis B vaccination
was systemic lupus erythematosus (SLE). She sought an award under the
National Vaccine Injury Compensation Program 3
On March 22, 2011, counsel for both
parties filed a stipulation, stating that a decision should be entered
awarding compensation. The parties stipulated that petitioner shall
receive the following compensation:
A lump sum of $
475,000.00 in the form of a check payable to petitioner as
Administratrix of the Estate of Tambra Harris. This amount represents
compensation for all damages that would be available under 42 U.S.C.
§300aa-15(a);
and
A lump sum payment of $
9,914.00 in the form of a check jointly payable to petitioner and the
State of Mississippi Division of Medicaid, Attn: Ms. Carolyn Hall
Williams, Third Party Liability Unit, 550 High Street, Walter Sillers
Building, Suite 1000, Jackson MS 39201, for reimbursement of
Mississippi’s Medicaid expenses related to Tambra’s care.
Stipulation ¶ 8(a) and ¶ 8(b).
The undersigned approves the requested
amount for petitioner’s compensation. Accordingly, an award should be
made in the form of a check payable to petitioner as Administratrix of
the Estate of Tambra Harris in the amount of $ 475,000.00. In
addition, an additional award should be made in the form of a check
payable jointly to petitioner and the State of Mississippi Division of
Medicaid in the amount of $ 9,914.00. In the absence of a motion for
review filed pursuant to RCFC Appendix B, the clerk of the court SHALL
ENTER JUDGMENT in accordance with the terms of the parties’ stipulation.
4
IT IS SO ORDERED.
s/Patricia E. Campbell-Smith
Patricia E. Campbell-Smith
Special Master.
s/Patricia E. Campbell-Smith
Patricia E. Campbell-Smith
Special Master.
1 Because this decision contains a
reasoned explanation for the undersigned’s action in this case, the
undersigned intends to post this decision on the United States Court of
Federal Claims’ website, in accordance with the E-Government Act of
2002, Pub. L. No. 107-347, 116 Stat. 2899, 2913 (Dec. 17, 2002). As
provided by Vaccine Rule 18(b), each party has 14 days within which to
request redaction “of any information furnished by that party: (1) that
is a trade secret or commercial or financial in substance and is
privileged or confidential; or (2) that includes medical files or
similar files, the disclosure of which would constitute a clearly
unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, “the
entire” decision will be available to the public. Id. (the Act or the
National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100
Stat. 3755, codified as amended, 42 U.S.C. §§ 300aa-1 to -34 (2006)
(Vaccine Act or the Act). All citations in this decision to individual
sections of the Vaccine Act are to 42 U.S.C. § 300aa.
2 Tambra Harris died on November 9, 2009.
Tambra’s mother and Administratix of her estate, Louvonia Deniece
Harris, was substituted as petitioner, and an amended petition was filed
on October 15, 2010.
3 The National Vaccine Injury Compensation Program is set forth in Part 2 of the Program). 42 U.S.C. §§ 300aa-1 to -34 (2006).
4 Pursuant to Vaccine Rule 11(a), entry
of judgment is expedited by the parties’ joint filing of notice
renouncing the right to seek review.
___________________________________________________________________
UK Government Caught Lying On Baby Hep B Vax Safety
Posted on April 13, 2009
The British Government has been
caught lying this week in news reports in two British Sunday newspapers
about a proposal to give 8 week old British babies Hepatitis B
vaccinations.
A Department of Health spokesman was quoted claiming:-
The safety of children is always paramount whenever decisions are taken regarding what vaccines are included as part of the child vaccination programme.“: New vaccination fears over plan to give hepatitis jabs at eight weeks old Mail on Sunday 12th April 2009, Vaccination fears over plan for Hepatitis B jabs for babies : Sunday Telegraph 12 Apr 2009.
Only cost and not safety is legally permitted to be an objection under the UK New Labour Government’s new law in effect from April 1 this year
[full details below]. Whilst 8 week old babies are not at risk from
Hepatitis B, they are from the vaccine [full details below]. And six five EU Hepatitis B vaccines have lost their marketing authorisations since 2000, the latest being last week – GlaxoSmithKline’s Hepatitis B Energix B vaccine [full details below].
Hepatitis B vaccine has been shown in many peer reviewed research papers [including
from Harvard University - detailed references at end] to be associated
with numerous infant deaths in the USA and Europe, multiple sclerosis
and numerous chronic auto-immune disorders. These latter
include Guillain-Barre syndrome, lupus, rheumatism, blood disorders and
chronic fatigue. The only potential claimed infant risk group is
alleged to be babies born in the UK to mothers from countries with
claimed-to-have high rates of infection. Around 2000 British born
infants are already being vaccinated annually in the UK. At risk groups
are intravenous “recreational” drug abusers and those who practice
unsafe sex – which rules out 8 week old babies.
There has been a criminal judicial
investigation in France into the adverse effects of this vaccine.
France was the first country to introduce universal Hepatitis B
vaccination and saw effects which included the first ever seen and
harrowing cases of childhood multiple sclerosis in France.
Research also shows that the
prevalence of Hepatitis B is low in the UK, consistent with previous
estimates and suggesting that many infections were acquired outside the
UK. This all suggests Government should
concentrate its efforts on effective treatment rather than vaccination
of infants against a disease which does not affect them. Proponents of
the vaccination claim rates of Hepatitis B infection are “spiralling”
but based on “estimates”. Regrettably “estimates” can be “pulled” in one
direction or another depending on which direction those responsible for
the “estimates” are more interested in seeing them move. And in these
circumstances, they can never be justification for vaccinating all
babies to protect adult drug abusers and practitioners of unsafe sex.
Additionally, UK and EU authorities have withdrawn marketing licences for 6 5 Hepatitis vaccines claiming a lack of efficacy in some cases, voluntary withdrawal by the applicant in others and denying in one case [Hexavac] any association with 6 infant deaths in Germany. The deaths were reported in a 2005 research paper as possibly caused by the vaccine: “Unexplained cases of sudden infant death shortly after hexavalent vaccination.” Zinka B, Rauch E, Buettner A, Rueff F, Penning R. – Vaccine. 2005 May 18.
The safety of the vaccine is not in question, but it is suspected to be ineffective.” MHRA recalls GSK’s Hepatitis B vaccine - 07 Apr 2009 - Regulatory Affairs – Hays Pharma News
The other most recent vaccine to lose its European marketing authorisation was Quintanrix [also from GSK] in August last year. The other vaccines are: Infanrix [GSK], Hepacare [Celltech] and Primavax [Aventis Pasteur].
So if ‘The safety of children is always paramount’ why the British Department of Health is even contemplating such a vaccine for 8 week old babies is beyond comprehension.”
And do vaccines cause autistic conditions? If you read nothing else we strongly recommend you read this: PDF Download – Text of May 5th 2008 email from US HRSA to Sharyl Attkisson of CBS News]. In it the US Health Resources Services Administration [HRSA] state to CBS News reporter Sharyl Attkisson
We have compensated cases in which children exhibited an encephalopathy, or general brain disease. Encephalopathy may be accompanied by a medical progression of an array of symptoms including autistic behavior, autism, or seizures.”
After the Hannah Poling story broke in the USA in February 2008 [see CHS article here]
under the media spotlight numerous US health officials and agencies
conceded on broadcast US nationwide TV news from CBS and CNN. Full
details with links to the original sources can be found in this CHS
article: Vaccination Causes Autism – Say US Government & Merck’s Director of Vaccines. Hannah developed an autistic condition after 9 vaccines administered the same day.
But there is worse to come and it
shows the UK’s New Labour Government has been irresponsible handing
recently from 1st April 2009 legal power to dictate vaccination policy
exclusively to the Joint Committee on Vaccination and Immunisation: UK Government Hands Drug Industry Control of Childhood Vaccination. The JCVI regrettably
has a demonstrable track-record of recklessness on safety up to and
including the present day, as shown in FOI documents: British Government’s Reckless Disregard for Child Health Safety and UK Government Hands Drug Industry Control of Childhood Vaccination.
The DoH statement published in The Mail on Sunday is also untrue because:-
- Under the new law The Health Protection (Vaccination) Regulations 2009 which came into effect on 1st April for England only, the Secretary of State has no power on the grounds of safety to refuse to implement or reverse any Joint Committe on Vaccination and Immunisation recommendation
- the JCVI expressly has no remit to take safety into account in its decision-making
- [that role is supposedly the MHRA's but regrettably they seem to rubber stamp a great deal of what the drug industry come up with - as has been shown time and again and not just with vaccines, but drugs like Seroxat - the "anti-depressant" shown not to work compared to placebo in some trials and which causes adolescents to be 3 times more likely to commit suicide in others.]
- the only consideration the Secretary of State can take into account in rejecting JCVI recommendations is cost-effectiveness – not safety
- contrary to the UK Department of Health claims, no childhood
vaccines used on British children have ever been tested according to the
gold standard of evidence – randomised placebo controlled clinical
trials.
- health officials refuse to ensure large scale studies of total health outcomes between vaccinated and unvaccinated individuals are carried out. These should show differences in overall health between these groups and some medical professionals believe this is because the studies would reveal the unvaccinated are healthier overall and high levels of chronic diseases in vaccinated individuals.
- there is no clinical benefit to infants from Hepatitis B vaccine but infants are put at risk of the known and unknown adverse effects
- this also means doctors and nurses are being expected to behave unethically and possibly criminally – because no caring parent will consent to a vaccine administered to an 8 week old baby on being told there are risks but no benefits
The main reason for the new drive to
more and more vaccines – and this is well published in the trade press –
is that the drug industry has been changing its business model. The
financial markets have known for many years the old model would fail –
that of patented “blockbuster” drugs:-
- the drug industry have made vaccines the new growth area because they are highly lucrative
- they are drugs everyone gets – it is the same business model of Bill Gates’ Microsoft – pretty much everyone has to have Windows software – pretty much everyone gets vax’d
- and the drug industry has been working hard behind-the-scenes to pursuade everyone – especially legislators – that they are vital when they are not and lobbying for changes in law just like this new law – which was introduced without Parliamentary debate and appears to be unlawful per se: UK Government Hands Drug Industry Control of Childhood Vaccination
Dr Marc Girard, a
specialist in the side effects of drugs and commissioned as a medical
expert by French courts in the French criminal investigation into the
introduction of universal Hepatitis B vaccination in France, suggests that even in high-endemic countries, the risk/benefit ratio of what he describes as “this unusually toxic vaccine” must be carefully re-assessed.
Regarding the health situation in the UK Dr Girard says the conclusion not to vaccinate is obvious. France was the first country to implement universal hepatitis B vaccination in 1994.
Whilst other evidence is embargoed by the French Courts, Dr. Marc Girard has
also been able to publish a scientific review of the unembargoed
evidence of the vaccine’s hazards (Autoimmun Rev 2005; 4: 96-100). Dr
Girard shows that French health authorities suppress studies
demonstrating serious risks.
Dr Girard has previously said:
Whilst the risk factors for babies have changed little, there is now impressive evidence that for a preventive measure, hepatitis B vaccine is remarkable for the frequency, variety and severity of complications from its use. The toxicity of this vaccine is so unusual that, even if crucial data are regrettably concealed or covered by Court order, scientific evidence is already far higher than normally needed to justify severe restrictive measures.“
______________________________________
REFERENCES
UK & EU MARKETING AUTHORISATION WITHDRAWALS
- MHRA recalls GSK’s Hepatitis B vaccine - 07 Apr 2009 - Regulatory Affairs – Hays Pharma News
- Public Statement on Quintanrix (Common name: diphtheria, tetanus, pertussis, hepatitis B, Haemophilus influenzae type b conjugate vaccine) Withdrawal of the Marketing Authorisation in the European Union – 29/08/08 – EMEA/424484/08
- EMEA announces recommendation for suspension of the marketing authorisation for Hexavac – EMEA/297369/2005
- EMEA Questions and Answers on the suspension of Hexavac - EMEA/304888/2005
- EMEA Withdrawal of the Marketing Authorisation for the Medicinal Product Hepacare (Triple hepatitis B recombinant vaccine)EMEA/32933/02- 20/12/02
- Public Statement on Hepacare (Triple hepatitis B recombinant vaccine)17/12/02 – EMEA/32933/02
- Withdrawal of the Marketing Authorisation for the Medicinal Product Primavax (Diptheria, Tetanus, and Hepatitis B vaccine) – 04/12/00 – EMEA/H/2681/00
______________________________________
DEATHS, MULTIPLE SCLEROSIS AND OTHER ADVERSE EFFECTS
- “Unexplained cases of sudden infant death shortly after hexavalent vaccination.” Zinka B, Rauch E, Buettner A, Rueff F, Penning R. – Vaccine. 2005 May 18
Vaccinations are considered to be the most effective and safe method preventing infectious diseases. Although hexavalent vaccines like Hexavac((R)) and Infanrix Hexa((R)) are assumed to be well tolerated and safe regarding the rate of immunity [Liese JG, Stojanov S, Berut F, Minini P, Harzer E, Jow S, et al. Large scale safety study of a liquid hexavalent vaccine (D-T-acP-IPV-PRP-T-HBs) administered at 2, 4, 6 and 12-14 months of age. Vaccine 2002;20:448-54; Mallet E, Fabre P, Pines E, Salomon H, Staub T, Schodel F, et al. Immunogenicity and safety of a new liquid hexavalent combines vaccine compared with separate administration of reference licensed vaccines in infants. Pediatr Infect Dis J 2000;19:1119-27], it was noticed that several cases of death occurred shortly after the vaccination. We report six cases of sudden infant death that occurred within 48h after hexavalent vaccination. At post-mortal examination, those cases showed unusual findings, especially in the brain and in laboratory tests. Crude calculations of local epidemiology are compatible with an association between hexavalent vaccination and unusual cases of sudden infant death. If confirmed in systematic studies, our findings would have potentially serious clinical implications.
Neonatal Deaths After Hepatitis B Vaccine – The Vaccine Adverse Event Reporting System, 1991-1998 – Arch Pediatr Adolesc Med. 1999;153:1279-1282
Results: Of 1771 neonatal reports, there were 18 deaths in 8 boys and 9 girls (1 patient unclassified). The mean age at vaccination for these 18 cases was 12 days(range, 1-27 days); median time from vaccination to onset of symptoms was 2 days (range, 0-20 days); and median time from symptoms to death was 0 days (range, 0-15 days). The mean birth weight of the neonates (n = 15) was 3034 g (range, 1828-4678 g). The causes of death for the 17 autopsied cases were sudden infant death syndrome for 12, infection for 3, and 1 case each of intracerebral hemorrhage, accidental suffocation, and congenital heart disease. Conclusion: Few neonatal deaths following HepB vaccination have been reported, despite the use of at least 86 million doses of pediatric vaccine given in the United States since 1991. While the limitations of passive surveillance systems do not permit definitive inference, these data suggest that HepB immunization is not causing a clear increase in neonatal deaths.
Recombinant hepatitis B vaccine and the risk of multiple sclerosis
NEUROLOGY 2004;63:838-842
A prospective study
Miguel A. Hernán, MD, DrPH, Susan S. Jick, DSc, Michael J. Olek, DO and Hershel Jick, MD
From the Department of Epidemiology (Dr.
Hernán), Harvard School of Public Health, Boston; Boston Collaborative
Drug Surveillance Program (Drs. Susan S. Jick and Hershel Jick), Boston
University, Lexington, MA; and Department of Neurology (Dr. Olek),
College of Medicine, University of California, Irvine.
Background: A
potential link between the recombinant hepatitisB vaccine and an
increased risk of multiple sclerosis (MS) hasbeen evaluated in several
studies, but some of them have substantialmethodologic limitations.
Methods: The
authors conducted a nested case-control study withinthe General Practice
Research Database (GPRD) in the UnitedKingdom. The authors identified
patients who had a first MSdiagnosis recorded in the GPRD between
January 1993 and December2000. Cases were patients with a diagnosis of
MS confirmed throughexamination of medical records, and with at least 3
years ofcontinuous recording in the GPRD before their date of
firstsymptoms (index date). Up to 10 controls per case were
randomlyselected, matched on age, sex, practice, and date of joiningthe
practice. Information on receipt of immunizations was obtainedfrom the
computer records.
Results: The
analyses include 163 cases of MS and 1,604 controls.The OR of MS for
vaccination within 3 years before the indexdate compared to no
vaccination was 3.1 (95% CI 1.5, 6.3). Noincreased risk of MS was
associated with tetanus and influenzavaccinations.
Conclusions:
These findings are consistent with the hypothesisthat immunization with
the recombinant hepatitis B vaccine isassociated with an increased risk
of MS, and challenge the ideathat the relation between hepatitis B
vaccination and risk ofMS is well understood.
Received March 31, 2004. Accepted in final form May 8, 2004.
“Multiple sclerosis and
hepatitis B vaccination: Adding the credibility of molecular biology to
an unusual level of clinical and epidemiological evidence” Comenge Y; Girard M (Med Hypotheses, doi 10.1016/j.mehy.2005.08.012)
“Autoimmune hazards of hepatitis B vaccine” Girard M (Autoimmun Rev 2005; 4:96-100) (Text available in electronic form on request.)
______________________________________
Low Prevalence in The UK of Hepatitis B and Infections acquired abroad
The prevalence of hepatitis B infection in adults in England and Wales – Epidemiology and Infection (1999), 122:133-138 Cambridge University Press
Cost effectiveness analyses of alternative hepatitis B vaccination programmes in England and Wales require a robust estimate of the lifetime risk of carriage. To this end, we report the prevalence of infection in 3781 anonymized individuals aged 15–44 years whose sera were submitted in 1996 to 16 microbiology laboratories in England and Wales. One hundred and forty-six individuals (3·9%) were confirmed as anti HBc positive, including 14 chronic carriers (0·37%). The prevalence of infection and carriage was higher in samples collected in London and increased with age. No increased risk of infection was seen in sera from genito-urinary (GUM) clinics. Only 15 sera positive for hepatitis B were also positive for hepatitis C. Our results confirm the low prevalence of hepatitis B in England and Wales, are consistent with previous estimates of carriage and suggest that many infections were acquired while resident outside the UK. Future prevalence studies should determine the country of birth and other risk factors for each individual in order to confirm these findings. (Accepted September 14 1998)
Filed under: ADHD, Aspergers, autism, Child Health Safety, Hannah Poling, John Poling, MMR, vaccination, vaccine, vaccine court, Vaccine Damage, Vaccines Tagged: | ADHD, Aspergers, autism, CDC, Centers for Disease Control, Child Health Safety, Disease Statistics, fraud, Hannah Poling, John Poling, MMR, research fraud, vaccination, vaccine, vaccine court, Vaccine Damage, Vaccines
Keep shining the light on these things, chs.
Meanwhile, parents who use physical and verbal abuse on a daily basis are deemed fit as long as the required medications are taken and they smile sweetly at the qualified deranged during assessment. They (child protection agents) simply don’t want damaged, disruptive children for sale; damaged goods.
The majority of newborn’s enter this world receiving a needle containing warfarin; getting one’s head around this fact will produce cognitive dissonance in the majority. Welcome to the world; prepare to die. Lovely.
And bring these corrupt medical practitioners to justice. Who have brought such ignominy to what should be a very honourable profession. And can still be; given the proper incentive. Of doing the very best for people. Not what’s in it for the medical-pharmaceutical-government complex.
People are up in arms about the destruction of the NHS in UK but they don’t see that it was birthed containing a lethal, self-detonating virus beneath the benevolent facade of universal health care. Why, the majority have the false notion that NHS is ‘free’! The virus within the conception of the NHS was the intention to outreach into every single womb on the land through successive generations. The purpose was depopulation; the purpose was control. Since the inception of the NHS, the military state has been given carte’ blanche’ to poison, disable and kill untold unborns, infants, children, adults. All who have been vaccinated have been brain damaged at the very least, me included. I’m aware I don’t know how my mind would work had it not been contaminated with at least 6 vaccines through childhood.
Nowadays, due to the hugely profitable child trafficking racket of fostering and adoption, SS agents get involved via NHS in every point of the generative cycle should there be profit in doing so. At any time and under any circumstances, children can be snatched away never to be seen again just because a parent objects to mandatory vaccination.
They are immediately tagged at risk if they refuse or object or hold reservation about their child receiving a toxic shot. So it’s very scary for parents to take a stand and hold it unless they are very well prepared for the potential consequences of doing so.
And so they should be. This is a very wicked world and to bring innocent fresh perfect life into this cesspit, the duty is to protect this purity. Unless you can do so, do you have the right to take on such a daunting responsibility? Are you up for it, for it will take everything you’ve got unless you have.
I’m retired from the US military. No wonder I’m disabled, with all the immunizations we were required to take. Damn Anthrax, Hep A & B shots. Merk is a menace to mankind.